- Home
- HSCS vs FTEL Comparison
HSCS vs FTEL Comparison
Compare HSCS & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- FTEL
- Stock Information
- Founded
- HSCS 2007
- FTEL 2007
- Country
- HSCS United States
- FTEL Australia
- Employees
- HSCS N/A
- FTEL N/A
- Industry
- HSCS Medical Specialities
- FTEL
- Sector
- HSCS Health Care
- FTEL
- Exchange
- HSCS Nasdaq
- FTEL Nasdaq
- Market Cap
- HSCS 8.7M
- FTEL 9.1M
- IPO Year
- HSCS 2022
- FTEL 2023
- Fundamental
- Price
- HSCS $3.46
- FTEL $0.46
- Analyst Decision
- HSCS Strong Buy
- FTEL
- Analyst Count
- HSCS 2
- FTEL 0
- Target Price
- HSCS $13.00
- FTEL N/A
- AVG Volume (30 Days)
- HSCS 87.4K
- FTEL 316.8K
- Earning Date
- HSCS 09-11-2025
- FTEL 04-28-2025
- Dividend Yield
- HSCS N/A
- FTEL N/A
- EPS Growth
- HSCS N/A
- FTEL N/A
- EPS
- HSCS N/A
- FTEL N/A
- Revenue
- HSCS $6,250.00
- FTEL $4,990,695.00
- Revenue This Year
- HSCS $13,968.97
- FTEL N/A
- Revenue Next Year
- HSCS $166.67
- FTEL N/A
- P/E Ratio
- HSCS N/A
- FTEL N/A
- Revenue Growth
- HSCS N/A
- FTEL 29.02
- 52 Week Low
- HSCS $2.52
- FTEL $0.36
- 52 Week High
- HSCS $6.47
- FTEL $49.50
- Technical
- Relative Strength Index (RSI)
- HSCS 50.77
- FTEL 44.71
- Support Level
- HSCS $3.00
- FTEL $0.39
- Resistance Level
- HSCS $3.70
- FTEL $0.68
- Average True Range (ATR)
- HSCS 0.21
- FTEL 0.06
- MACD
- HSCS 0.02
- FTEL 0.01
- Stochastic Oscillator
- HSCS 65.71
- FTEL 23.94
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.